TransCode Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| UBS GROUP AG | 01/29/2026 | 2.96 K | $20.25 K | 100.00% | 0.43% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 887 | $6.06 K | 524.65% | 0.13% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 10 | $68 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 8 | $55 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 3 | $20 | 0.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TransCode Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 8 institutional investors and hedge funds held shares of TransCode Therapeutics Inc. The most heavily invested institutionals were:
Tower Research Capital LLC (TRC): 887
BANK OF AMERICA CORP /DE/: 8
ADVISOR GROUP HOLDINGS, INC.: 3
CITIGROUP INC: 0
Federation des caisses Desjardins du Quebec: 0
DRW Securities, LLC: 0
0.56% of TransCode Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 898 shares in the last 24 months. This purchase volume represents approximately $8.68 K in transactions.